These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1345811)

  • 1. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
    Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR.
    Shimizu M; Yokota J; Mori N; Shuin T; Shinoda M; Terada M; Oshimura M
    Oncogene; 1990 Feb; 5(2):185-94. PubMed ID: 1969617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion mapping in human renal cell carcinoma.
    Bergerheim U; Nordenskjöld M; Collins VP
    Cancer Res; 1989 Mar; 49(6):1390-6. PubMed ID: 2924296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
    Yamakawa K; Morita R; Takahashi E; Hori T; Ishikawa J; Nakamura Y
    Cancer Res; 1991 Sep; 51(17):4707-11. PubMed ID: 1678685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic deletions in renal tumors: histopathological correlations.
    Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
    Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.
    van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH
    Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
    Lott ST; Lovell M; Naylor SL; Killary AM
    Cancer Res; 1998 Aug; 58(16):3533-7. PubMed ID: 9721855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotype of renal cell carcinoma.
    Morita R; Ishikawa J; Tsutsumi M; Hikiji K; Tsukada Y; Kamidono S; Maeda S; Nakamura Y
    Cancer Res; 1991 Feb; 51(3):820-3. PubMed ID: 1670999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD; Johnson LD; Silva FG; Kovacs G
    Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
    Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
    Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.